Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
| dc.contributor.author | Balik, Ahmet Yildirim | |
| dc.contributor.author | Ediz, Emre | |
| dc.contributor.author | Ayvacik, Burak | |
| dc.contributor.author | Taskiran, Arda Taskin | |
| dc.contributor.author | Basaran, Ekrem | |
| dc.contributor.author | Baba, Dursun | |
| dc.date.accessioned | 2026-07-01T11:39:44Z | |
| dc.date.available | 2026-07-01T11:39:44Z | |
| dc.date.issued | 2026 | |
| dc.department | Düzce Üniversitesi | |
| dc.description.abstract | Objectives To compare the effectiveness and safety of two antibiotic prophylaxis regimens, ciprofloxacin plus gentamicin and ceftriaxone plus cefixime, in preventing infectious complications after transrectal ultrasound-guided prostate biopsy.Methods The study retrospectively reviewed 705 consecutive patients who underwent transrectal ultrasound-guided prostate biopsy between January 2020 and January 2024. Group 1 (n = 374) received ciprofloxacin plus gentamicin, and Group 2 (n = 331) received ceftriaxone plus cefixime. All patients underwent standard rectal preparation with povidone-iodine, and needle-tip disinfection with formalin. The primary outcome was the development of post-biopsy infectious complications, while secondary outcomes included sepsis and infection-related hospitalization.Results The two groups were comparable in terms of age, body mass index, prostate-specific antigen levels, and comorbidities. The overall rate of post-biopsy infection was 1.4%, occurring in 1.1% patients in Group 1 and 1.8% patients in Group 2 (p = 0.61). The incidence of complicated urinary tract infection was 0.3% versus 0.9%, and infection-related hospitalization occurred in 0.5% versus 0.3% of patients in Group 1 and Group 2, respectively, with no cases of sepsis observed. In univariable analyses, diabetes mellitus, histopathological chronic prostatitis, and pre-biopsy antibiotic use were not significantly associated with post-biopsy infection.Conclusion The combination of ceftriaxone and cefixime showed a safety profile broadly consistent with the combination of ciprofloxacin and gentamicin for biopsy prophylaxis. Considering increasing fluoroquinolone resistance and growing restrictions, this cephalosporin-based regimen may be considered a feasible option for transrectal ultrasound-guided prostate biopsy when implemented together with strict antiseptic measures. | |
| dc.identifier.doi | 10.1111/iju.70445 | |
| dc.identifier.issn | 0919-8172 | |
| dc.identifier.issn | 1442-2042 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pmid | 41891504 | |
| dc.identifier.scopus | 2-s2.0-105034117436 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1111/iju.70445 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12684/23450 | |
| dc.identifier.volume | 33 | |
| dc.identifier.wos | WOS:001748549000005 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.ispartof | International Journal of Urology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20260623 | |
| dc.subject | [Keyword Not Available] | |
| dc.title | Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin | |
| dc.type | Article |












